Literature DB >> 4760525

The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications.

B Drewinko, B W Brown, J A Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4760525

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  20 in total

1.  CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population.

Authors:  M Tsuchiya; Y Nakajima; T Waku; H Hiyoshi; T Morishita; R Furumai; Y Hayashi; H Kishimoto; K Kimura; J Yanagisawa
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

2.  Local chemotherapy with cisplatin-depot for glioblastoma multiforme.

Authors:  Sergey V Sheleg; Eugeny A Korotkevich; Edvard A Zhavrid; Galina V Muravskaya; Arnold F Smeyanovich; Yury G Shanko; Tatsiana L Yurkshtovich; Pavel B Bychkovsky; Sergey A Belyaev
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

3.  Sensitivity of rodent osteosarcoma clones to platinum-containing phosphonic acid complexes in vitro.

Authors:  T Klenner; P Valenzuela-Paz; B K Keppler; H R Scherf
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 4.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

5.  Phase II study of 5-day continuous infusion of cis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer.

Authors:  Y Saito; K Mori; K Tominaga; K Yokoi; N Miyazawa
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501).

Authors:  Norisuke Nakayama; Wasaburo Koizumi; Satoshi Tanabe; Tohru Sasaki; Katsunori Saigenji
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

7.  Prolongation of G1 phase in cultured glioma cells by cis-dichlorodiammineplatinum (II) (CDDP): analysis using bromodeoxyuridine (BrdU)-Hoechst technique.

Authors:  T Morimura
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

8.  Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer.

Authors:  Y Saito; K Mori; K Tominaga; K Yokoi; N Miyazawa
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer.

Authors:  H Saito; K Shimokata; M Yamamoto; H Saka; S Sakai; H Saito
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Cell survival after the combined action of manganese (MnCl2) and X-rays in synchronized Chinese hamster cells.

Authors:  Y Skreb; B Nagy
Journal:  Arch Toxicol       Date:  1984-11       Impact factor: 5.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.